| dc.contributor.author | APHRC | |
| dc.contributor.author | PPSU | |
| dc.contributor.author | MoH | |
| dc.contributor.author | CDC | |
| dc.contributor.author | KEMRI | |
| dc.date.accessioned | 2024-07-25T07:51:39Z | |
| dc.date.available | 2024-07-25T07:51:39Z | |
| dc.date.issued | 2022 | |
| dc.identifier.uri | https://covid.kemri-wellcome.org/wp-content/uploads/2021/06/High-prevalence-of-antibodies-against-COVID-19-within-the-general-population-Evidence-from-Nairobi-and-Kilifi.pdf | |
| dc.identifier.uri | http://knowhub.aphrc.org/handle/123456789/1443 | |
| dc.description.abstract | Since February 2022, KWTRP and the African Population and Health Research Center (APHRC) have conducted surveillance for COVID-19 antibody levels among residents of the Kilifi Health and Demographic Surveillance System (HDSS) and the Nairobi Urban HDSS . This Policy Brief summarizes preliminary estimates of the proportion of the population with COVID-19 antibodies at the two sites. | |
| dc.publisher | KEMRI-Wellcome | |
| dc.subject | Prevalence of antibodies against COVID-19 | |
| dc.subject | Nairobi | |
| dc.subject | Kilifi | |
| dc.title | High Prevalence of Antibodies Against COVID-19 Within the General Population: Evidence From Nairobi and Kilifi | |
